585 related articles for article (PubMed ID: 27226065)
41. Differences in Overall and Cancer-specific Survival of Patients Presenting With Chromophobe Versus Clear Cell Renal Cell Carcinoma: A Propensity Score Matched Analysis.
Frees S; Kamal MM; Knoechlein L; Bell R; Ziesel C; Neisius A; Thomas C; Brenner W; Jäger W; Thüroff JW; Roos FC
Urology; 2016 Dec; 98():81-87. PubMed ID: 27262395
[TBL] [Abstract][Full Text] [Related]
42. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus.
Haddad AQ; Leibovich BC; Abel EJ; Luo JH; Krabbe LM; Thompson RH; Heckman JE; Merrill MM; Gayed BA; Sagalowsky AI; Boorjian SA; Wood CG; Margulis V
Urol Oncol; 2015 Sep; 33(9):388.e1-9. PubMed ID: 26004163
[TBL] [Abstract][Full Text] [Related]
43. Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes.
Simone G; Tuderti G; Ferriero M; Papalia R; Misuraca L; Minisola F; Costantini M; Mastroianni R; Sentinelli S; Guaglianone S; Gallucci M
Eur J Surg Oncol; 2016 Nov; 42(11):1744-1750. PubMed ID: 27593224
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients.
Wu J; Chen L; Wang Y; Tan W; Huang Z
Onco Targets Ther; 2019; 12():5201-5213. PubMed ID: 31308692
[TBL] [Abstract][Full Text] [Related]
45. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
46. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
47. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
48. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Wang B; Hu L; Chen Y; Zhu B; Kong W; Zhu Z; Wang K; Yu Q; Zhang W; Wu G; Sun Y; Xia Z
Burns; 2022 Jun; 48(4):872-879. PubMed ID: 34456097
[TBL] [Abstract][Full Text] [Related]
49. Diabetes Mellitus as an Independent Predictor of Survival of Patients Surgically Treated for Renal Cell Carcinoma: A Propensity Score Matching Study.
Lee H; Kwak C; Kim HH; Byun SS; Lee SE; Hong SK
J Urol; 2015 Dec; 194(6):1554-60. PubMed ID: 26066406
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.
Ahmadabad MA; Naeimi A; Keymoradzadeh A; Faghani S; Ahmadabad MA; Boroujeni NA; Mohammadpour H; Saberi A
BMC Neurol; 2022 Dec; 22(1):450. PubMed ID: 36463106
[TBL] [Abstract][Full Text] [Related]
51. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
52. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
[TBL] [Abstract][Full Text] [Related]
53. Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis.
Su S; Liu L; Li C; Zhang J; Li S
Front Oncol; 2020; 10():1650. PubMed ID: 33014827
[No Abstract] [Full Text] [Related]
54. Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up.
Yokoyama M; Watanabe T; Otaki Y; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Konta T; Shibata Y; Daimon M; Ueno Y; Kato T; Kayama T; Kubota I
Dis Markers; 2016; 2016():4857917. PubMed ID: 27872510
[No Abstract] [Full Text] [Related]
55. Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma.
Chen SL; Li JP; Li LF; Zeng T; He X
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294917
[TBL] [Abstract][Full Text] [Related]
56. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
[TBL] [Abstract][Full Text] [Related]
57. Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: a meta-analysis of literature.
Men H; Liang C; Yu M
J Cancer Res Ther; 2015; 11(1):67-72. PubMed ID: 25879339
[TBL] [Abstract][Full Text] [Related]
58. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.
Yin G; Man C; Liao S; Qiu H
Mediators Inflamm; 2020; 2020():5719751. PubMed ID: 33376452
[TBL] [Abstract][Full Text] [Related]
59. Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.
Martella O; Galatioto GP; Necozione S; Pomante R; Vicentini C
Arch Ital Urol Androl; 2011 Sep; 83(3):121-7. PubMed ID: 22184835
[TBL] [Abstract][Full Text] [Related]
60. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
Ramankulov A; Lein M; Kristiansen G; Meyer HA; Loening SA; Jung K
J Cancer Res Clin Oncol; 2007 Sep; 133(9):643-52. PubMed ID: 17479289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
